New allergy nasal spray passes first safety check in healthy volunteers
NCT ID NCT07345442
First seen Jan 20, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This early-stage study tested a new nasal spray called PA9159 in 36 healthy Chinese adults. The goal was to check its safety and how the body processes it, not to treat any disease. Participants received either the spray or a placebo for up to 7 days, and researchers monitored for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Conditions
Explore the condition pages connected to this study.